Key complex product approval in the Affordable Medicines segment this yearCommercial launch planned for third quarter of 2025 BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte®. Pred Forte and its design are trademarks of Allergan, Inc., an AbbVie company. Launch of this product is planned for th ...

莎普爱思（603168）公告，公司近日收到国家药品监督管理局核发的左氧氟沙星滴眼液《药品补充申请 批准通知书》。该药品适应菌种包括葡萄球菌属、链球菌属等，适应症为眼睑炎、结膜炎等。公司已取 得该药品的《药品注册证书》，并累计研发投入约为593.05万元。获得批准通知书有助于提升该产品的 市场竞争力。 ...